Insider · CIK 0001772259

Cui Jingrong Jean

Reports to the SEC for 2 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001772259

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-10	BLSMBlossomHill Therapeutics, Inc.C Conversion	Director, President and CEO, 10% Owner	CConversion	+125K sh	—	—	124,779
2026-08-10	BLSMBlossomHill Therapeutics, Inc. · Series B Preferred StockC Conversion	Director, President and CEO, 10% Owner	CConversion	−125K sh	—	—	0
2026-08-10	BLSMBlossomHill Therapeutics, Inc.C Conversion	Director, President and CEO, 10% Owner	CConversion	+1.6M sh	—	—	1,600,682
2026-08-10	BLSMBlossomHill Therapeutics, Inc.C Conversion	Director, President and CEO, 10% Owner	CConversion	+113K sh	—	—	1,714,117
2026-08-10	BLSMBlossomHill Therapeutics, Inc. · Series Angel Preferred StockC Conversion	Director, President and CEO, 10% Owner	CConversion	−1.6M sh	—	—	0
2026-08-10	BLSMBlossomHill Therapeutics, Inc. · Series B Preferred StockC Conversion	Director, President and CEO, 10% Owner	CConversion	−113K sh	—	—	0
2026-08-06	BLSMBlossomHill Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director, President and CEO, 10% Owner	AAward	+676K sh	—	—	676,205
2020-06-09	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−300 sh	$67.48	−$20.2K	540,383
2020-06-09	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−412 sh	$63.80	−$26.3K	549,471
2020-06-09	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−1,688 sh	$64.82	−$109K	547,783
2020-06-09	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−2,585 sh	$66.60	−$172K	540,683
2020-06-09	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−4,515 sh	$65.80	−$297K	543,268
2020-06-08	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−10.7K sh	$63.36	−$676K	555,844
2020-06-08	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−1,872 sh	$62.50	−$117K	566,511
2020-06-08	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−5,961 sh	$63.92	−$381K	549,883
2020-06-05	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−3,602 sh	$63.04	−$227K	583,281
2020-06-05	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−4,671 sh	$65.03	−$304K	569,683
2020-06-05	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−8,927 sh	$64.04	−$572K	574,354
2020-06-05	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−1,300 sh	$65.66	−$85.4K	568,383
2020-06-04	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−3,688 sh	$63.88	−$236K	596,195
2020-06-04	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−3,600 sh	$62.70	−$226K	599,883
2020-06-04	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−1,900 sh	$61.76	−$117K	603,483
2020-06-04	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−2,072 sh	$68.62	−$142K	587,711
2020-06-04	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−828 sh	$69.54	−$57.6K	586,883
2020-06-04	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−1,800 sh	$67.52	−$122K	589,783
2020-06-04	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−600 sh	$65.81	−$39.5K	591,583
2020-06-04	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−4,012 sh	$64.67	−$259K	592,183
2020-05-21	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−6,900 sh	$59.64	−$412K	605,483
2020-05-21	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−100 sh	$60.34	−$6,034	605,383
2020-05-20	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−1,400 sh	$60.98	−$85.4K	612,383
2020-05-20	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−500 sh	$59.04	−$29.5K	618,883
2020-05-20	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−5,100 sh	$60.03	−$306K	613,783
2020-05-19	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−3,000 sh	$58.36	−$175K	619,783
2020-05-19	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−1,200 sh	$56.33	−$67.6K	625,183
2020-05-19	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−2,400 sh	$57.44	−$138K	622,783
2020-05-19	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−400 sh	$58.94	−$23.6K	619,383
2020-05-08	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−730 sh	$52.53	−$38.3K	637,153
2020-05-08	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−5,920 sh	$53.49	−$317K	631,233
2020-05-08	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−4,750 sh	$54.49	−$259K	626,483
2020-05-08	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−100 sh	$55.16	−$5,516	626,383
2020-05-07	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−1,330 sh	$53.70	−$71.4K	637,883
2020-05-07	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−5,306 sh	$52.22	−$277K	651,077
2020-05-07	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−11.9K sh	$53.05	−$629K	639,213
2020-05-06	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−6,072 sh	$52.54	−$319K	668,811
2020-05-06	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−12.4K sh	$53.13	−$660K	656,383
2020-05-05	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−5,784 sh	$54.67	−$316K	674,883
2020-05-05	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−3,998 sh	$53.05	−$212K	689,385
2020-05-05	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−8,718 sh	$54.04	−$471K	680,667
2020-04-24	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−300 sh	$51.98	−$15.6K	693,383
2020-04-24	Turning Point Therapeutics, Inc.S Sale	Director	SSale	−3,487 sh	$51.31	−$179K	693,683

Recent filings

Accepted (ET)
Aug 104
Cui Jingrong Jean0001772259-26-000005
SEC(opens sec.gov)
Jun 104
Cui Jingrong Jean0001209191-20-035621
SEC(opens sec.gov)
Jun 84
Cui Jingrong Jean0001209191-20-035149
SEC(opens sec.gov)

Companies

Address

C/O BLOSSOMHILL THERAPEUTICS, INC. 10255 SCIENCE CENTER DRIVE, SUITE 200

SAN DIEGO, CA, 92121